Riccardo Mazza։ Personalized Anticoagulation in Atrial Fibrillation
Riccardo Mazza, Cardiology Resident at University Vita-Salute San Raffaele, shared a post on LinkedIn about a recent article he co-authored with Cosmo Godino, adding:
՛՛Our response to the Letter to the Editor by Magdelijns et al. has been published in the Journal of Thrombosis and Haemostasis.
The concept of ‘one-size-fits-all’ anticoagulation may have limitations in contemporary AF management.
Personalized anticoagulation is progressively moving from theoretical consideration to clinical discussion.
We are grateful for the ongoing scientific discussion and look forward to the results of the DOAC-FRAIL trial.՛՛
Title: Plasma levels measurement of the 4 direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events: reply
Authors: Cosmo Godino, Riccardo Mazza
Read the Full Article on Journal of Thrombosis and Haemostasis․
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulnessof CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine